Adoptive cancer immunotherapy utilizing lymphokine activated killer cells and gamma interferon activated killer monocytes.
D000818:Animals; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects; D008222:Lymphokines / Q000627:therapeutic use*; D009000:Monocytes / Q000187:drug effects; D009369:Neoplasms / Q000628:therapy*
D008222:Lymphokines; D007371:Interferon-gamma